Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Psyence looking to be a major player in psychedelics using their federally licensed facilities

Psyence looking to be a major player in psychedelics using their federally licensed facilities

Psyence BioMed (CSE: PSYG) CEO Jody Aufrichtig joined Steve Darling from Proactive to shares news about this newly listed company that is one of the few to have built and operate a Federally licensed commercial psilocybin cultivation and production facilities.

Aufrichtig telling Proactive about that facility and how they plan to move forward with their Therapeutics, Production, Experience and Function

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK